NO985172D0 - Feline vaksiner inneholdende chlamydia psittaci og fremgangsmÕter for fremstilling derav - Google Patents

Feline vaksiner inneholdende chlamydia psittaci og fremgangsmÕter for fremstilling derav

Info

Publication number
NO985172D0
NO985172D0 NO985172A NO985172A NO985172D0 NO 985172 D0 NO985172 D0 NO 985172D0 NO 985172 A NO985172 A NO 985172A NO 985172 A NO985172 A NO 985172A NO 985172 D0 NO985172 D0 NO 985172D0
Authority
NO
Norway
Prior art keywords
preparation
methods
vaccines containing
chlamydia psittaci
containing chlamydia
Prior art date
Application number
NO985172A
Other languages
English (en)
Other versions
NO320871B1 (no
NO985172L (no
Inventor
Rebecca A Atherton
Norbert Schmeer
Jean A Hallstrom
Jennifer K Lane
Kristina J Hennessy
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO985172D0 publication Critical patent/NO985172D0/no
Publication of NO985172L publication Critical patent/NO985172L/no
Publication of NO320871B1 publication Critical patent/NO320871B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19985172A 1996-05-06 1998-11-05 Inaktivert, immunogent effektiv og ikke-reaktiv Chlamydia psittaci vaksine, og fremgangsmater for fremstilling derav. NO320871B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/643,673 US5972350A (en) 1996-05-06 1996-05-06 Feline vaccines containing Chlamydia psittaci and method for making the same
PCT/US1997/007514 WO1997041889A1 (en) 1996-05-06 1997-04-21 Feline vaccines containing chlamydia psittaci and method for making the same

Publications (3)

Publication Number Publication Date
NO985172D0 true NO985172D0 (no) 1998-11-05
NO985172L NO985172L (no) 1999-01-06
NO320871B1 NO320871B1 (no) 2006-02-06

Family

ID=24581818

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985172A NO320871B1 (no) 1996-05-06 1998-11-05 Inaktivert, immunogent effektiv og ikke-reaktiv Chlamydia psittaci vaksine, og fremgangsmater for fremstilling derav.

Country Status (16)

Country Link
US (1) US5972350A (no)
EP (1) EP0904106A1 (no)
JP (1) JP2000510121A (no)
AU (1) AU717628B2 (no)
BG (1) BG63564B1 (no)
BR (1) BR9708975A (no)
CA (1) CA2203234A1 (no)
CZ (1) CZ297848B6 (no)
EE (1) EE04516B1 (no)
IL (1) IL126628A (no)
NO (1) NO320871B1 (no)
NZ (1) NZ332620A (no)
PL (1) PL329734A1 (no)
SK (1) SK149198A3 (no)
TR (1) TR199802259T2 (no)
WO (1) WO1997041889A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010048927A1 (en) * 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
US20050202046A1 (en) * 2004-03-11 2005-09-15 Wyeth Canine vaccine for protection against ehrlichiosis
US7306807B2 (en) 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
CN100423775C (zh) * 2005-04-15 2008-10-08 中国农业科学院兰州兽医研究所 牛衣原体病灭活疫苗及其制备与检验方法
CN101849013A (zh) * 2007-05-30 2010-09-29 惠氏有限责任公司 猫抗原的浣熊痘病毒表达基因
FR3039406B1 (fr) * 2015-07-28 2020-09-18 Centre Nat Rech Scient Composition vaccinale contre les infections a chlamydiaceae

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
BR9407986A (pt) * 1993-11-03 1996-12-03 Pfizer Vacina e método para tratamento de infecçoes clamídicas

Also Published As

Publication number Publication date
EE04516B1 (et) 2005-08-15
EE9800388A (et) 1999-06-15
CZ360498A3 (cs) 1999-03-17
CA2203234A1 (en) 1997-11-06
TR199802259T2 (xx) 1999-02-22
NZ332620A (en) 2000-04-28
AU717628B2 (en) 2000-03-30
BG102890A (en) 1999-09-30
NO320871B1 (no) 2006-02-06
CZ297848B6 (cs) 2007-04-11
MX9703278A (es) 1998-05-31
US5972350A (en) 1999-10-26
SK149198A3 (en) 2000-02-14
PL329734A1 (en) 1999-04-12
BG63564B1 (bg) 2002-05-31
EP0904106A1 (en) 1999-03-31
IL126628A0 (en) 1999-08-17
NO985172L (no) 1999-01-06
JP2000510121A (ja) 2000-08-08
BR9708975A (pt) 1999-08-03
AU2996297A (en) 1997-11-26
WO1997041889A1 (en) 1997-11-13
IL126628A (en) 2002-09-12

Similar Documents

Publication Publication Date Title
IS4879A (is) Efnablöndur dreifanlegra stórsameinda og aðferðirtil gerðar þeirra og notkunar
NO973365D0 (no) Fremgangsmåte for baking og tilhörende anordning
NO982329D0 (no) Kreftvaksine og fremgangsmÕte for fremstilling derav
BR9305976A (pt) Dispositivo para preparação de amostras
BR9607726A (pt) Dispositivo e método para retração de tecido gengival
NO993288D0 (no) Antimikrobiell handske og fremgangsmÕte for fremstilling derav
IL126271A0 (en) 2-Arylpyrazolisoquinoline and cinnolinone derivatives methods for their preparation and pharmaceutical formulations containing them
IL136308A0 (en) Antipicornaviral compounds and methods for their use and preparation
NO972477D0 (no) Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse
BR9608705A (pt) Método e aparelho para retirar amostra
SG74075A1 (en) Baggage pusher device system and method of use
ITMI951283A0 (it) Gel di allumina mesoporoso e procedimento per la sua preparazione
BR9605702A (pt) Alourante para cabelos humanos
NO965023L (no) Maltitolblanding og fremstilling derav
NO985172D0 (no) Feline vaksiner inneholdende chlamydia psittaci og fremgangsmÕter for fremstilling derav
NO971505D0 (no) Trofinin og trofininhjelperproteiner
NO990914D0 (no) Amorfe benzotiofener, fremgangsmÕter for fremstilling og fremgangsmÕter for anvendelse
KR960007598A (ko) 비스락톤계화합물 및 그 제조방법
NO952261D0 (no) Antacidiumforbindelser og fremgangsmåte for fremstilling derav
DK1042286T3 (da) Gamme-glutamyl- og beta-aspartyl-holdige immunmodulerende forbindelser og tilhørense fremgangsmåder
NO962782L (no) Farmasöytiske formuleringer omfattende polytiourea, og metode for anvendelse derav
NO985572D0 (no) Substituerte amidinobenzenderivater og medisinske preparater derav
NO995649D0 (no) Anordning og fremgangsmåte for rehydrering og ekstrudering
NO932638L (no) 21-klor-pregnanderivat og fremgangsmaater for dets fremstilling
HUP9902924A3 (en) Feline vaccines containing chlamydia psittaci and method for making the same